This e-book provides a comprehensive overview of the state of the art of fluid biomarkers for AD, e.g. which novel biomarkers should be implemented in clinical practice for diagnosis or for monitoring treatment or side effects, which ones ...

Distils the most valuable discoveries in dementia research into clear, insightful chapters written by international experts.

This volume covers the latest methods used in clinical neurochemistry laboratories for both clinical practice and research.

Throughout, a practical approach is adopted, geared specifically to the needs of clinicians (neurologists, radiologists, psychiatrists, geriatricians) working in the field of dementia, for whom this book should prove an invaluable resource.

Parkinson's Disease: Improving Patient Care is a clinically-focused text for healthcare professionals involved in everyday management of Parkinson's disease patients.

... amyloid ß proteins 1-40 and 1-42 in Alzheimer disease . Arch . Neurol . 2000 ... Dementia Diagnosis in Patients with Intermediate P - tau181P Levels . J ... CSF amyloid beta ( AB ) 1-42 and the CSF AB 1-42 / AB 1-40 ratio — A ...

Filling a noticeable gap in the market for a new text solely focused on Dementia with Lewy Bodies, this book discusses cutting-edge topics covering the condition from diagnosis to management, as well as what is known about the ...

This new volume provides a unique source of reference to the important work being done in this field, it gives academics and clinicians an opportunity to learn about cutting edge developments and covers all aspects of Alzheimer's Disease, ...

This book, written by the most outstanding scientists in this new filed, is the first presentation of results concerning the implications of apolipoprotein E on the genetics, cell biology, neuropathology, biochemistry, and therapeutic ...

This book effectively highlights and frames inequalities in all areas across the translational spectrum from bench-to-bedside and from boardroom-to-policy and economics.